Bardy Diagnostics says Seattle-area health providers are using its Carnation ambulatory monitor (CAM) patch to measure QT segments in COVID-19 patients prescribed hydroxychloroquine (HCQ) experimentally. Hospitals across the city in their protocals have slated the local company’s CAM patch for use monitoring cardiac rhythms after coronavirus patients on HCQ are discharged from the hospital, as […]
Bardy Diagnostics
50 medtech startups you need to know
Medical device industry accelerator MedTech Innovator today announced about 50 medtech startups participating in its annual four-month program. Half are early-stage companies participating in MedTech Innovator’s Accelerator and Showcase program, and the other half are mid-stage companies in the organization’s Showcase program. The list of companies is a who’s who of people around the world […]
Bardy Diagnostics raises $36m in Series B
Bardy Diagnostics said this week that it raised $35.5 million in a round of Series B financing. The round was led by River Cities Capital Funds and joined by newly invested HealthQuest Capital, Aperture Venture Partners, Aphelion Capital, Lumira Ventures and Rex Health Ventures. Existing investors SV Health Investors, Health Enterprise Partners and Ascension Ventures […]
11 pediatric cardiovascular devices you need to know about
A bandage-sized heart monitor, an extracorporeal blood pump that mimics the human heart, and a heart valve that can grow with a child were among the six winners of a contest in Philadelphia for innovative pediatric cardiovascular devices. The Pediatric Device Innovation Symposium organized by the Sheikh Zayed Institute for Pediatric Surgical Innovation at Children’s National […]
HRS 2018 Roundup: Device-related blood clots with Boston Scientific’s Watchman implant
Data from a study of device-related blood clots and the Watchman cardiac implant made by Boston Scientific (NYSE:BSX), presented today at the annual meeting of the Heart Rhythm Society in Boston, indicate the need for aggressive management of patients at risk for device-related thrombosis. There were 74 incidences of DRT in 65 of the 1,739 Watchman […]
SV Life Sciences gets in on ‘significant’ round for Bardy Diagnostics
Healthcare investor SV Life Sciences joined a ‘significant round of growth capital’ for medtech developer Bardy Diagnostics and its Carnation cardiac monitor and arrhythmia detection device. The Charlotte, N.C.-based company’s Carnation ambulatory monitor is a non-invasive P-wave centric ambulatory cardiac monitor and arrhythmia detection device which the company touts as the world’s smallest and lightest […]